These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24124095)

  • 1. Tetrahydroisoquinolinone-based steroidomimetic and chimeric microtubule disruptors.
    Leese MP; Jourdan FL; Major MR; Dohle W; Hamel E; Ferrandis E; Fiore A; Kasprzyk PG; Potter BV
    ChemMedChem; 2014 Jan; 9(1):85-108, 1. PubMed ID: 24124095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, antitubulin, and antiproliferative SAR of C3/C1-substituted tetrahydroisoquinolines.
    Dohle W; Leese MP; Jourdan FL; Major MR; Bai R; Hamel E; Ferrandis E; Kasprzyk PG; Fiore A; Newman SP; Purohit A; Potter BV
    ChemMedChem; 2014 Feb; 9(2):350-70. PubMed ID: 24436228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinones.
    Leese MP; Jourdan FL; Major MR; Dohle W; Thomas MP; Hamel E; Ferrandis E; Mahon MF; Newman SP; Purohit A; Potter BV
    ChemMedChem; 2014 Apr; 9(4):798-812. PubMed ID: 24596315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors.
    Dohle W; Leese MP; Jourdan FL; Chapman CJ; Hamel E; Ferrandis E; Potter BV
    ChemMedChem; 2014 Aug; 9(8):1783-93. PubMed ID: 24819406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology-oriented synthesis of a tetrahydroisoquinoline-based compound collection targeting microtubule polymerization.
    Zimmermann TJ; Roy S; Martinez NE; Ziegler S; Hedberg C; Waldmann H
    Chembiochem; 2013 Feb; 14(3):295-300. PubMed ID: 23364933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors.
    Leese MP; Jourdan F; Dohle W; Kimberley MR; Thomas MP; Bai R; Hamel E; Ferrandis E; Potter BV
    ACS Med Chem Lett; 2012 Jan; 3(1):5-9. PubMed ID: 22247790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
    Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
    Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure.
    Dohle W; Jourdan FL; Menchon G; Prota AE; Foster PA; Mannion P; Hamel E; Thomas MP; Kasprzyk PG; Ferrandis E; Steinmetz MO; Leese MP; Potter BVL
    J Med Chem; 2018 Feb; 61(3):1031-1044. PubMed ID: 29227648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure.
    Dohle W; Prota AE; Menchon G; Hamel E; Steinmetz MO; Potter BVL
    ACS Omega; 2019 Jan; 4(1):755-764. PubMed ID: 30775645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives as potential antitumor candidate.
    Zhu P; Ye W; Li J; Zhang Y; Huang W; Cheng M; Wang Y; Zhang Y; Liu H; Zuo J
    Chem Biol Drug Des; 2017 Mar; 89(3):443-455. PubMed ID: 27717183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors.
    Kraus Y; Glas C; Melzer B; Gao L; Heise C; Preuße M; Ahlfeld J; Bracher F; Thorn-Seshold O
    Eur J Med Chem; 2020 Jan; 186():111865. PubMed ID: 31735573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
    Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
    Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
    Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
    J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer.
    Colley HE; Muthana M; Danson SJ; Jackson LV; Brett ML; Harrison J; Coole SF; Mason DP; Jennings LR; Wong M; Tulasi V; Norman D; Lockey PM; Williams L; Dossetter AG; Griffen EJ; Thompson MJ
    J Med Chem; 2015 Dec; 58(23):9309-33. PubMed ID: 26580420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydropathic analysis and biological evaluation of stilbene derivatives as colchicine site microtubule inhibitors with anti-leukemic activity.
    Tripathi A; Durrant D; Lee RM; Baruchello R; Romagnoli R; Simoni D; Kellogg GE
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1237-44. PubMed ID: 19912057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery of novel indazole derivatives as tubulin colchicine site binding agents that displayed potent antitumor activity both in vitro and in vivo.
    Cui YJ; Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2020 Feb; 187():111968. PubMed ID: 31865012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Design, Synthesis, and Biological Activities of Pyrrole-Based Carboxamides: The Novel Tubulin Inhibitors Targeting the Colchicine-Binding Site.
    Boichuk S; Galembikova A; Syuzov K; Dunaev P; Bikinieva F; Aukhadieva A; Zykova S; Igidov N; Gankova K; Novikova M; Kopnin P
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.